The following video is from today's MarketFoolery podcast, in which host Chris Hill, along with Jeff Fischer and Joe Magyer, discuss the latest business news. Shares of MAKO Surgical fell 43% today after the company cut its sales forecast for the RIO robotic arm orthopedic system for the second time in two months. In this segment, the guys analyze the questions the company faces, including whether management has a handle on the company's internal challenges and from competitors like Intuitive Surgical. After such a huge sell-off, is the time ripe for investors to buy shares? The guys discuss whether the opportunity is better for individuals or for a company like Stryker to take out MAKO all by itself.
Few technology companies have disrupted industries the way Intuitive Surgical has. And while tech giant Facebook is the largest company to IPO, Facebook still has the challenge of creating new ways to make money off the hundreds of millions of people who populate the site. We've created a new report, "Forget Facebook -- Here's the Tech IPO You Should Be Buying," which details a much better social-media stock that has a longer runway for growth than Facebook. The report won't be available forever, so click here to get access today -- it's totally free.
At the time thisarticle was published Chris Hillowns no shares of any of the companies mentioned. The Motley Fool owns shares of MAKO Surgical and Intuitive Surgical.Motley Fool newsletter serviceshave recommended buying shares of Intuitive Surgical, MAKO Surgical, and Stryker. The Motley Fool has adisclosure policy. We Fools don't all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. Try any of our Foolish newsletter servicesfree for 30 days.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.